Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses

Immunocompromised individuals generally fail to mount efficacious immune humoral responses following vaccination. The emergence of SARS-CoV-2 variants of concern has raised the question as to whether levels of anti-spike protein antibodies achieved after two or three doses of the vaccine efficiently...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed-Belkacem, Abdelhakim, Redjoul, Rabah, Brillet, Rozenn, Ahnou, Nazim, Leclerc, Mathieu, López-Molina, Dennis Salomón, Soulier, Alexandre, Gourgeon, Aurélie, Rodriguez, Christophe, Maury, Sébastien, Pawlotsky, Jean-Michel, Fourati, Slim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506309/
https://www.ncbi.nlm.nih.gov/pubmed/36146735
http://dx.doi.org/10.3390/v14091928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506309/
https://www.ncbi.nlm.nih.gov/pubmed/36146735
http://dx.doi.org/10.3390/v14091928

Ejemplares similares